Page 94 - girbes

Lingwood, D. y Simons, K. (2010). Lipid rafts as a membrane-organizing
principle. Science, 327: 46-50.

Liu, B., Bian, H. y Bao, J. (2010). Plant lectins: potential antineoplastic
drugs from bench to clinic. Cancer Lett., 287, 1–12.

Loh, S., Park, J., Cho, E., Nah, S. y Kang, Y. (2017). Animal lectins:
potential receptors for ginseng polysaccharides. J. Ginseng Res., 41: 1-9.

Lord, J., Roberts, L., y Robertus, J. (1994) Ricin: structure, mode of action,
and some current applications. FASEB J., 8: 201-208.

Magnusson, S., Kjeken, R., y Berg, T. (1993). Characterization of two
distinct pathways of endocytosis of ricin by rat liver endothelial cells. Exp.
Cell Res., 205: 118–125.

Martínez-Carmona, M., Izquierdo, I., Colilla, M. y Vallet-Regí, M. (2019).
Concanavalin A-targeted mesoporous silica nanoparticles for infection
treatment. Acta Biomateralia, 96: 549-556.
Martínez-Carmona, M., Lozano, D., Colilla, M. y Vallet-Regí, M. (2018).
Lectin-conjugated pH-responsive mesoporous silica nanoparticles for
targeted bone cancer treatment. Acta Biomateralia, 65: 393-404.

McEver, R. (2015). Selectins: initiators of leucocyte adhesion and
signalling at the vascular wall. Cardiovasc Res., 107:331-339.

Mitchell, S.W. (1860). Researches upon the venom of the rattlesnake.
Smithson Contrib. Knowl., XII: 89–90.

Montfort, W., Villafranca, J., Monzingo, A., Ernst, S., Katzin, B.,
Rutenber, E., Xuong, N., Hamlin, R., y Robertus, J.D. (1987). The three-
dimensional structure of ricin at 2.8 Å. J. Biol. Chem., 262: 5398-5403.

Muñoz, R., Arias, Y, Ferreras, J.M, Rojo, A. Jiménez, P y Girbés, T. (2001)
Sensitivity of several cancer cell lines to ricin and the novel type 2 ribosome-
inactivating protein nigrin b. Cancer Lett., 167: 163-169.

Muñoz, R., Arias, Y., Ferreras, J., Rojo, M., Gayoso, M., Nocito, M.,
Benitez, J., Jimenez, P., Bernabeu, C., y Girbes, T. (2007). Targeting a
marker of the tumour neovasculature using a novel anti-human CD105-
immunotoxin containing the non-toxic type 2 ribosome-inactivating protein
nigrin b. Cancer Lett., 256: 73–80.

92